Moreover, another cohort from the TCGA database found that oral cancer patients with high co-expression of EGFR and SQSTM1 had poor DSS (AHR = 2.53, 95% CI = 1.46–4.39, p = 0.001; Table 4) but not DFS. Here, EGFR is linked to lip and oral cavity carcinoma.